دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Survival After Septal Reduction in Patients >65 Years Old With Obstructive Hypertrophic Cardiomyopathy
Amgad Mentias, MD, MS, Nicholas G. Smedira, MD, MBA, Amar Krishnaswamy, MD, Grant W. Reed, MD, MS C, Susan Ospina, NP, Maran Thamilarasan, MD, Zoran B. Popovic, MD, P HD, Bo Xu, MD, Samir R. Kapadia, MD, Milind Y. Desai, MD, MBA
doi : 10.1016/j.jacc.2022.10.027
Volume 81, Issue 2, 17 January 2023, Pages 105-115
Obstructive hypertrophic cardiomyopathy (oHCM) is increasingly being diagnosed in elderly patients.
Increased Long-Term Survival After Myectomy: Is the Pendulum Swinging Again in This 30-Year Debate?∗
Martin S. Maron, MD
doi : 10.1016/j.jacc.2022.11.008
Volume 81, Issue 2, 17 January 2023, Pages 116-118
Regional Antibiotic Delivery for Implanted Cardiovascular Electronic Device Infections
Moris Topaz, MD, PHD, a,b, * Ehud Chorin, MD, PHD, a,c, * Arie Lorin Schwartz, MD, a,c Aviram Hochstadt, MD,a,c Avraham Shotan, MD,d,e,f Itamar Ashkenazi, MD,g Mark Kazatsker, MD, d Narin-Nard Carmel, MD,c Guy Topaz, MD,c,h Yoram Oron, P HD, c Gilad Margolis, MD,a,c Eyal Nof, MD,c,i Roy Beinart, MD,c,i Michael Glikson, MD,c,i,j Anna Mazo, MD,a,c Anat Milman, MD, P HD, c,i Michal Dekel, MD, c,k Shmuel Banai, MD,a,c Raphael Rosso, MD,a,c Sami Viskin, MDa
doi : 10.1016/j.jacc.2022.10.022
Volume 81, Issue 2, 17 January 2023, Pages 119-133
Present guidelines endorse complete removal of cardiovascular implantable electronic devices (pacemakers/defibrillators), including extraction of all intracardiac electrodes, not only for systemic infections, but also for localized pocket infections.
Treatment of Localized Implantable Cardiac Device Pocket Infections
Anne B. Curtis, MD, Aamir Ahmed, MD
doi : 10.1016/j.jacc.2022.11.018
Volume 81, Issue 2, 17 January 2023, Pages 134-135
Elevated LDL Triglycerides and Atherosclerotic Risk
Elevated LDL Triglycerides and Atherosclerotic Risk Mie Balling, MD,a,b,c Shoaib Afzal, MD, PHD, DMS C,a,b,c George Davey Smith, MD, DS C,d,e Anette Varbo, MD, P HD, a,b,c Anne Langsted, MD, PHD, a,b,c Pia R. Kamstrup, MD, PH D, a,b Børge G. Nordestgaard, MD, DMS C
doi : 10.1016/j.jacc.2022.10.019
Volume 81, Issue 2, 17 January 2023, Pages 136-152
It is unclear whether elevated low-density lipoprotein (LDL) triglycerides are associated with an increased risk of atherosclerotic cardiovascular disease (ASCVD).
Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease Risk
P. Barton Duell, MD
doi : 10.1016/j.jacc.2022.11.013
Volume 81, Issue 2, 17 January 2023, Pages 153-155
Improving Risk Stratification for Patients With Type 2 Myocardial Infarction
Caelan Taggart, MD, a, * Karla Monterrubio-Gómez, PHD, b, * Andreas Roos, MD, P HD, c,d Jasper Boeddinghaus, MD,a Dorien M. Kimenai, PHD, a Erik Kadesjo, MD, PHD, c,e Anda Bularga, MD,a Ryan Wereski, MD,a Amy Ferry, P HD, a Matthew Lowry, MD,a Atul Anand, MD, PHD, a Kuan Ken Lee, MD,a Dimitrios Doudesis, MSC ,a,f Ioanna Manolopoulou, PH D, g Thomas Nestelberger, MD,h Luca Koechlin, MD,h Pedro Lopez-Ayala, MD,h Christian Mueller, MD, h Nicholas L. Mills, MD, PH D, a,f Catalina A. Vallejos, PH D, b,i Andrew R. Chapman, MD, P HD
doi : 10.1016/j.jacc.2022.10.025
Volume 81, Issue 2, 17 January 2023, Pages 156-168
Despite poor cardiovascular outcomes, there are no dedicated, validated risk stratification tools to guide investigation or treatment in type 2 myocardial infarction.
Type 2 Myocardial Infarction: Do We Need Risk Scores?
Yader Sandoval, MD, a,b Allan S. Jaffe, MD
doi : 10.1016/j.jacc.2022.11.010
Volume 81, Issue 2, 17 January 2023, Pages 169-171
Takayasu Arteritis: JACC Focus Seminar 3/4
George Joseph, DM,a Ruchika Goel, DM, b Viji S. Thomson, DM,a Elizabeth Joseph, DNB, c Debashish Danda, DM
doi : 10.1016/j.jacc.2022.09.051
Volume 81, Issue 2, 17 January 2023, Pages 172-186
Takayasu arteritis is a rare idiopathic large-vessel vasculitis that typically affects young women.
Nutritional Heart Disease and Cardiomyopathies: JACC Focus Seminar 4/4
Karen Sliwa, MD, PH D, a,b Charle Andre Viljoen, MBC HB, a,b Babar Hasan, MD, c Ntobeko A.B. Ntusi, MBC HB, DP HIL, MD
doi : 10.1016/j.jacc.2022.08.812
Volume 81, Issue 2, 17 January 2023, Pages 187-202
This JACC Focus Seminar provides an overview of and highlights recently published research on cardiomyopathies and nutritional heart disease that have a higher prevalence in tropical regions.
Sex Disparities in Familial Hypercholesterolemia
Amanda Jiménez, MD, PhD Clara Viñals, MD, PhD Victoria Marco-BenedÃ, MD Pilar González, MD Mónica Domenech, MD, PhD Manuel Suárez-Tembra, MD Xavier Pinto, MD *Emilio Ortega, MD, PhD
doi : 10.1016/j.jacc.2022.10.023
Volume 81, Issue 2, 17 January 2023, Pages 203-205
American Heart Association “Moderate-Risk� Patients Develop Infectious Endocarditis After Dental Extractions
Arthur H. Friedlander, DMD *Paulo H. Couto-Souza, DDS, PhD
doi : 10.1016/j.jacc.2022.09.052
Volume 81, Issue 2, 17 January 2023, Page e13
Reply: American Heart Association “Moderate-Risk� Patients Develop Infectious Endocarditis After Dental Extractions
Martin H. Thornhill, MBBS, BDS, PhD Mark J. Dayer, MBBS, PhD Peter B. Lockhart, DDS Patrick T. O’Gara, MD Larry M. Baddour, MD
doi : 10.1016/j.jacc.2022.10.026
Volume 81, Issue 2, 17 January 2023, Page e15
